Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma

NCT02739204 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Oral Squamous Cell Carcinoma

Interventions

DRUG: Celecoxib

Sponsor

China Medical University Hospital

Collaborators

[object Object]